Starpharma Holdings Ltd
PQ6
Company Profile
Business description
Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.
Contact
4-6 Southampton Crescent
Abbotsford
MelbourneVIC3067
AUST: +61 385322700
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2025
Employees
32
Stocks News & Analysis
stocks
Why ASX miners will handily beat banks in the long-term
After a stellar run for banks, investors are wondering whether they can continue their outperformance or if a rotation into miners is imminent. There’s a good case that a switch is coming, and it may last decades, not just years.
stocks
How to avoid dividend disaster
Thinking about common reasons a company might stop paying a dividend can help income investors avoid disappointment.
video
Do you qualify as 'rich'?
Morningstar's Sim Mody speaks with Mark LaMonica about the varying definitions of rich.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,785.10 | 101.70 | 1.17% |
CAC 40 | 8,001.97 | 110.29 | 1.40% |
DAX 40 | 21,866.98 | 281.05 | 1.30% |
Dow JONES (US) | 44,857.18 | 16.10 | -0.04% |
FTSE 100 | 8,748.11 | 124.82 | 1.45% |
HKSE | 20,891.62 | 294.53 | 1.43% |
NASDAQ | 19,710.22 | 17.89 | 0.09% |
Nikkei 225 | 39,066.53 | 235.05 | 0.61% |
NZX 50 Index | 12,844.59 | 60.45 | -0.47% |
S&P 500 | 6,070.37 | 8.89 | 0.15% |
S&P/ASX 200 | 8,520.70 | 103.80 | 1.23% |
SSE Composite Index | 3,270.66 | 41.17 | 1.27% |